| Home | E-Submission | Sitemap | Editorial Office |  
top_img
    
ORIGINAL ARTICLE 2018 February 5
S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
Purpose We conducted a randomized, multicenter, phase III trial to compare S-1 plus docetaxel (DS) with S-1 plus cisplatin (SP) as adjuvant chemotherapy for stage III gastric cancer patients. Materials and Methods Stage III gastric cancer patients who had received curative ga...
ORIGINAL ARTICLE 2018 February 5
Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma
Purpose The purpose of this study was to investigate the impact of contrast enhanced pancreatic magnetic resonance imaging (MRI) in resectability and prognosis evaluation after staging computed tomography (CT) in patients with pancreatic ductal adenocarcinoma (PDA). Materials ...
ORIGINAL ARTICLE 2018 February 6
The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era
Purpose We aim to examine nasopharyngeal carcinoma (NPC) characteristics and survival outcomes in patients aged 70 years and older in the intensity-modulated radiotherapy (IMRT) era. Methods and Materials From 2006 to 2013, 126 non-metastatic NPC patients aged ≥ 70 years who...
ORIGINAL ARTICLE 2018 February 14
Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
Purpose We investigated whether irinotecan plus capecitabine improved progression-free survival (PFS) compared with capecitabine alone in patients with human epidermal growth factor 2 (HER2) negative and anthracycline and taxane pretreated metastatic breast cancer (MBC). Mate...
Current Issue
Volume 51(1); Jan 2019
Volume 50(4); October 2018
Volume 50(3); July 2018
RSS feed
  • Most-cited are based on citations from 2017 ~ 2019.
  • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
    Kyu-Won Jung, Young-Joo Won, Chang-Mo Oh, Hyun-Joo Kong, Duk Hyoung Lee, Kang Hyun Lee, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2017;49(2):292-305.   Published online March 9, 2017    DOI: https://doi.org/10.4143/crt.2017.118
                                     Cited By 173
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015
    Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2018;50(2):303-316.   Published online March 21, 2018    DOI: https://doi.org/10.4143/crt.2018.143
                                     Cited By 46
    Prediction of Cancer Incidence and Mortality in Korea, 2017
    Kyu-Won Jung, Young-Joo Won, Chang-Mo Oh, Hyun-Joo Kong, Duk Hyoung Lee, Kang Hyun Lee
    Cancer Res Treat. 2017;49(2):306-312.   Published online March 17, 2017    DOI: https://doi.org/10.4143/crt.2017.130
                                     Cited By 34
    Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
    Hae Il Jung, Dongjun Jeong, Sanghee Ji, Tae Sung Ahn, Sang Ho Bae, Susie Chin, Jun Chul Chung, Hyung Chul Kim, Moon Soo Lee, Moo-Jun Baek
    Cancer Res Treat. 2017;49(1):246-254.   Published online July 7, 2016    DOI: https://doi.org/10.4143/crt.2016.066
                                     Cited By 23
    Trends in Participation Rates for the National Cancer Screening Program in Korea, 2002-2012
    Mina Suh, Seolhee Song, Ha Na Cho, Boyoung Park, Jae Kwan Jun, Eunji Choi, Yeol Kim, Kui Son Choi
    Cancer Res Treat. 2017;49(3):798-806.   Published online November 11, 2016    DOI: https://doi.org/10.4143/crt.2016.186
                                  Supplementary         Cited By 14
    An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer
    In Hae Park, Joo Hyuk Sohn, Sung Bae Kim, Keun Seok Lee, Joo Seop Chung, Soo Hyeon Lee, Tae You Kim, Kyung Hae Jung, Eun Kyung Cho, Yang Soo Kim, Hong Suk Song, Jae Hong Seo, Hun Mo Ryoo, Sun Ah Lee, So Young Yoon, Chul Soo Kim, Yong Tai Kim, Si Young Kim, Mi Ryung Jin, Jungsil Ro
    Cancer Res Treat. 2017;49(3):569-577.   Published online September 12, 2016    DOI: https://doi.org/10.4143/crt.2016.289
                                     Cited By 13
    Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review
    Li-Tzong Chen, Do-Youn Oh, Min-Hee Ryu, Kun-Huei Yeh, Winnie Yeo, Roberto Carlesi, Rebecca Cheng, Jongseok Kim, Mauro Orlando, Yoon-Koo Kang
    Cancer Res Treat. 2017;49(4):851-868.   Published online January 3, 2017    DOI: https://doi.org/10.4143/crt.2016.176
                                  Supplementary         Cited By 13
    Lung Cancer Epidemiology in Korea
    Aesun Shin, Chang-Mo Oh, Byung-Woo Kim, Hyeongtaek Woo, Young-Joo Won, Jin-Soo Lee
    Cancer Res Treat. 2017;49(3):616-626.   Published online September 23, 2016    DOI: https://doi.org/10.4143/crt.2016.178
                                  Supplementary         Cited By 12
    Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer
    In Hye Song, Sun-Hee Heo, Won Seon Bang, Hye Seon Park, In Ah Park, Young-Ae Kim, Suk Young Park, Jin Roh, Gyungyub Gong, Hee Jin Lee
    Cancer Res Treat. 2017;49(2):399-407.   Published online July 27, 2016    DOI: https://doi.org/10.4143/crt.2016.215
                                  Supplementary         Cited By 11
    Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity
    Jörg U. Schmohl, Martin Felices, Felix Oh, Alexander J. Lenvik, Aaron M. Lebeau, Jayanth Panyam, Jeffrey S. Miller, Daniel A. Vallera
    Cancer Res Treat. 2017;49(4):1140-1152.   Published online February 20, 2017    DOI: https://doi.org/10.4143/crt.2016.491
                                     Cited By 11
    Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia
    Mathias Lutz, Arik B. Schulze, Elisabeth Rebber, Stefanie Wiebe, Tarek Zoubi, Oliver M. Grauer, Torsten Keßler, Andrea Kerkhoff, Georg Lenz, Wolfgang E. Berdel
    Cancer Res Treat. 2017;49(2):548-552.   Published online July 12, 2016    DOI: https://doi.org/10.4143/crt.2016.110
                                     Cited By 10
    Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway
    Boyun Kim, Hee Seung Kim, Soochi Kim, Guy Haegeman, Benjamin K. Tsang, Danny N. Dhanasekaran, Yong Sang Song
    Cancer Res Treat. 2017;49(2):338-349.   Published online July 18, 2016    DOI: https://doi.org/10.4143/crt.2016.175
                                     Cited By 10
    Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis
    Kyung Su Kim, Jeanny Kwon, Kyubo Kim, Eui Kyu Chie
    Cancer Res Treat. 2017;49(3):824-833.   Published online August 26, 2016    DOI: https://doi.org/10.4143/crt.2016.336
                                     Cited By 10
    The Generation and Application of Patient-Derived Xenograft Model for Cancer Research
    Jaeyun Jung, Hyang Sook Seol, Suhwan Chang
    Cancer Res Treat. 2018;50(1):1-10.   Published online September 13, 2017    DOI: https://doi.org/10.4143/crt.2017.307
                                     Cited By 10
    Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort
    Minkyu Jung, Jeeyun Lee, Tae Min Kim, Dae Ho Lee, Jin Hyung Kang, Sung Young Oh, Soo Jung Lee, Sang Joon Shin
    Cancer Res Treat. 2017;49(1):44-53.   Published online April 27, 2016    DOI: https://doi.org/10.4143/crt.2016.024
                                     Cited By 9
    Trends and Age-Period-Cohort Effects on the Incidence and Mortality Rate of Cervical Cancer in Korea
    Eun-Kyeong Moon, Chang-Mo Oh, Young-Joo Won, Jong-Keun Lee, Kyu-Won Jung, Hyunsoon Cho, Jae Kwan Jun, Myong Cheol Lim, Moran Ki
    Cancer Res Treat. 2017;49(2):526-533.   Published online September 1, 2016    DOI: https://doi.org/10.4143/crt.2016.316
                                     Cited By 9
    Long Non-coding RNA HOXA11 Antisense Promotes Cell Proliferation and Invasion and Predicts Patient Prognosis in Serous Ovarian Cancer
    Ga Won Yim, Hee Jung Kim, Lee Kyung Kim, Sang Wun Kim, Sunghoon Kim, Eun Ji Nam, Young Tae Kim
    Cancer Res Treat. 2017;49(3):656-668.   Published online October 11, 2016    DOI: https://doi.org/10.4143/crt.2016.263
                                     Cited By 9
    Prediction of Cancer Incidence and Mortality in Korea, 2018
    Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee
    Cancer Res Treat. 2018;50(2):317-323.   Published online March 21, 2018    DOI: https://doi.org/10.4143/crt.2018.142
                                     Cited By 9
    Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea
    Jae Young Joung, Jiwon Lim, Chang-Mo Oh, Kyu-Won Jung, Hyunsoon Cho, Sung Han Kim, Ho Kyung Seo, Weon Seo Park, Jinsoo Chung, Kang Hyun Lee, Young-Joo Won
    Cancer Res Treat. 2017;49(3):607-615.   Published online September 23, 2016    DOI: https://doi.org/10.4143/crt.2016.139
                                  Supplementary         Cited By 8
    FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation
    Jinju Park, Yiseul Choi, Young San Ko, Younghoon Kim, Jung-Soo Pyo, Bo Gun Jang, Min A Kim, Jae-Seon Lee, Mee Soo Chang, Jong-Wan Park, Byung Lan Lee
    Cancer Res Treat. 2018;50(1):239-254.   Published online March 24, 2017    DOI: https://doi.org/10.4143/crt.2016.580
                                     Cited By 8
    Korean Cancer Association
    E-Submission
    EndNote Output Style
    Email Alert
    Cancer Research and Treatment 2017; 49(4): 915-926.
    Impact factor
    SCImago Journal & Country Rank
    PubMed Central
    MEDLINE/PubMed
    Scopus
    KoreaMed
    KoMCI
    ScienceCentral
    GoogleScholar
    Similarity Check
    Crossref Cited-by Linking
    CrossMark
    Funder Registry
    ORCID
    COPE
    Editorial Office
    Korean Cancer Association
    Room 1824, Gwanghwamun Officia
    92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
    TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
    About |  Browse Articles |  Current Issue |  For Authors and Reviewers
    Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2Community